Open access · CC-BY
via OpenAlex
Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
Zhong’e Zhou, Yong Tang, Xian Jin, Chengjun Chen, Yi Lu, Liang Liu, Chengxing Shen
Journal of Diabetes Research · 2016 · ▲ 126 citations
Abstract
Advanced glycation end products (AGEs) are major inflammatory mediators in diabetes, affecting atherosclerosis progression via macrophages. Metformin slows diabetic atherosclerosis progression through mechanisms that remain to be fully elucidated. The present study of murine bone marrow derived macrophages showed that (1) AGEs enhanced proinflammatory cytokines (interleukin-1β(IL-1β), IL-6, and tumor necrosis factor-α(TNF-α)) mRNA expression, RAGE expression, and NFκB activation; (2) metformin pretreatment inhibited AGEs effects and AGEs-induced cluster designation 86 (CD86) (M1 marker) expression, while promoting CD206 (M2 marker) surface expression and anti-inflammatory cytokine (IL-10) mRNA expression; and (3) the AMPK inhibitor, Compound C, attenuated metformin effects. In conclusion, metformin inhibits AGEs-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE/NFκB pathway suppression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2016/4847812
- Canonical
- link ↗
- Fetched
- 2026-08-24 MST
Cite this
APA
Zhou, Z., Tang, Y., Jin, X., Chen, C., Lu, Y., Liu, L., & Shen, C. (2016). Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. <em>Journal of Diabetes Research</em>. https://doi.org/10.1155/2016/4847812
Vancouver
Zhou Z, Tang Y, Jin X, Chen C, Lu Y, Liu L, et al. Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. Journal of Diabetes Research. 2016. doi:10.1155/2016/4847812.
BibTeX
@article{zhonge2016Metfor,
title = {Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression},
author = {Zhong’e Zhou and Yong Tang and Xian Jin and Chengjun Chen and Yi Lu and Liang Liu and Chengxing Shen},
journal = {Journal of Diabetes Research},
year = {2016},
doi = {10.1155/2016/4847812},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Padova 2010
Open access · US-GOV
Effects of Metformin on Longevity Gene Expression and Inflammation and Prediabetic Individuals. A Placebo-controlled Trial
Aging Cell 2013
Open access · OA
Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK / NF ‐κ B activation
Circulation Research 2016
Open access · CC-BY
Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Molecular Therapy — Methods & Clinical Development 2020
Open access · CC-BY
Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion
Pharmaceutical Biology 2016
Open access · OA
Healing effects of sumac (Rhus coriaria) in streptozotocin-induced diabetic rats
Bone 2026
Citation only